Benzinga | Nov 8, 2021 06:04AM EST

Beam Therapeutics Q3 EPS $(0.42) Up From $(0.69) YoY

Beam Therapeutics (NASDAQ:BEAM) reported quarterly losses of $(0.42) per share. This is a 39.13 percent increase over losses of $(0.69) per share from the same period last year.